Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right Ventricular Cardiomyopathy: A Comparison of Clinical and Quality-of-Life Outcomes.

Weijia Wang,Alessio Gasperetti,Samuel F Sears,Crystal Tichnell,Brittney Murray,Harikrishna Tandri,Cynthia A James,Hugh Calkins

JACC: Clinical Electrophysiology（2023）

引用 6|浏览15

暂无评分

摘要

In patients with ARVC receiving an ICD, the risk of inappropriate shocks from a subcutaneous ICD should be balanced against the significant vascular complication risk from a transvenous ICD. Patients with a subcutaneous ICD had more concerns for body image and range of motion.

查看译文

关键词

arrhythmogenic right ventricular cardiomyopathy,implantable defibrillator,quality of life,ventricular arrhythmia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要